Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

KU-0058948 is an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1) and PARP2 (IC50s = 3.4 and 1.5 nM, respectively).1 It is selective for PARP1 over PARP3, PARP4, and tankyrase (IC50s = 40, 1,200, and >10,000 nM, respectively). It also selectively inhibits the survival of mouse embryonic stem cells lacking Brca1 or Brca2 over mouse embryonic stem cells expressing wild-type Brca1 or Brca2. KU-0058948 (1 µM) induces apoptosis in P39 and MUTZ-3 acute myeloid leukemia (AML) cells.2 It decreases the survival of P39 and MUTZ-3 cells but not a variety of other AML and non-AML cells, including ME-1, U937, HL-60, and K562 cells. KU-0058948 (5 nM) potentiates cytotoxicity induced by MS-275 (Item No. 13284) in patient-derived AML cells. It reduces survival of HCT116 cells deficient in phosphatase and tensin homolog (PTEN) but not those expressing wild-type PTEN or containing a PTEN construct (HCT116+/neo).3
WARNING This product is not for human or veterinary use.
1. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434(7035), 917-921 (2005).
2. Inhibitors of poly ADP-
3. Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors. EMBO Mol. Med. 1(6-7), 315-322 (2009).